A phase I, randomized, single-dose pharmacokinetic study comparing sb8 (bevacizumab biosimilar) with reference bevacizumab in healthy volunteers

類似資料

• Comparative pharmacokinetics of an adalimumab biosimilar SB5 administered via autoinjector or prefilled syringe in healthy subjects
  著者:: Shin, Donghoon, 等
  出版事項: (2018)
• Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers
  著者:: Choi, Chungam, 等
  出版事項: (2018)
• A randomized phase l pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel®) in healthy subjects
  著者:: Lee, Yoon Jung, 等
  出版事項: (2016)
• SB8: A Bevacizumab Biosimilar
  著者:: Syed, Yahiya Y.
  出版事項: (2020)
• A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers
  著者:: Knight, Beverly, 等
  出版事項: (2016)